Literature DB >> 18336793

Comparative properties of recombinant human and bovine matrix metalloproteinase-20.

Li Zhu1, Katoro Tanimoto, Sarah Robinsin, James Chen, Ewa Witkowska, Steve Hall, Thuan Le, Pamela K Denbesten, Wu Li.   

Abstract

INTRODUCTION: Matrix metalloproteinase-20 (MMP-20) is a predominant enzyme for the progressive processing of enamel extracellular matrix protein components (primarily amelogenin) during the early stages of enamel formation. So far, the recombinant porcine, mouse and bovine MMP-20 have been cloned and used extensively in the researches of tooth enamel development. The homology of these MMP-20s to human MMP-20 is approximately 80%. The effect of sequence differences on the properties of these enzymes is poorly understood even though they have been used to hydrolyse amelogenins from different species.
OBJECTIVE: Our goal is to compare the characteristics between recombinant human MMP-20 (rhMMP-20) and bovine MMP-20 (rbMMP-20).
DESIGN: rhMMP-20 and rbMMP-20 were parallelly expressed, purified and activated. The SDS-PAGE, zymography and quenched peptide assay were used for characterization and comparisons.
RESULTS: Both proteases were activated by autocatalysis in a similar pattern of fragmentation. Dynamically, rbMMP-20 autoactivated faster and digested a fluorescence-quenched peptide Mca-PLGL-Dpa-AR, a non-amelogenin substrate, more efficiently than rhMMP-20. However, rhMMP-20 showed higher enzymatic activity for a human amelogenin substrate and in addition, it created an extra cleavage site at its C-terminus.
CONCLUSIONS: The differences in their catalytic properties and substrate specificities may be attributed to the sequence divergence of MMP-20 between species, especially in the hinge region.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336793      PMCID: PMC2516969          DOI: 10.1016/j.archoralbio.2008.02.001

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  14 in total

1.  Cloning, characterization, and expression analysis of mouse enamelysin.

Authors:  J Caterina; J Shi; X Sun; Q Qian; S Yamada; Y Liu; S Krakora; J D Bartlett; Y Yamada; J A Engler; H Birkedal-Hansen; J P Simmer
Journal:  J Dent Res       Date:  2000-09       Impact factor: 6.116

2.  Regulation and interactions of MT1-MMP and MMP-20 in human odontoblasts and pulp tissue in vitro.

Authors:  H Palosaari; Y Ding; M Larmas; T Sorsa; J D Bartlett; T Salo; L Tjäderhane
Journal:  J Dent Res       Date:  2002-05       Impact factor: 6.116

3.  Enamelysin (matrix metalloproteinase-20): localization in the developing tooth and effects of pH and calcium on amelogenin hydrolysis.

Authors:  M Fukae; T Tanabe; T Uchida; S K Lee; O H Ryu; C Murakami; K Wakida; J P Simmer; Y Yamada; J D Bartlett
Journal:  J Dent Res       Date:  1998-08       Impact factor: 6.116

4.  Cloning, expression, purification, and characterization of rat MMP-12.

Authors:  J Y Fu; A Lyga; H Shi; M L Blue; B Dixon; D Chen
Journal:  Protein Expr Purif       Date:  2001-03       Impact factor: 1.650

5.  Characterization of recombinant pig enamelysin activity and cleavage of recombinant pig and mouse amelogenins.

Authors:  O H Ryu; A G Fincham; C C Hu; C Zhang; Q Qian; J D Bartlett; J P Simmer
Journal:  J Dent Res       Date:  1999-03       Impact factor: 6.116

Review 6.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

7.  Reduced hydrolysis of amelogenin may result in X-linked amelogenesis imperfecta.

Authors:  W Li; C W Gibson; W R Abrams; D W Andrews; P K DenBesten
Journal:  Matrix Biol       Date:  2001-01       Impact factor: 11.583

8.  Activation of recombinant bovine matrix metalloproteinase-20 and its hydrolysis of two amelogenin oligopeptides.

Authors:  W Li; D Machule; C Gao; P K DenBesten
Journal:  Eur J Oral Sci       Date:  1999-10       Impact factor: 2.612

9.  Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue.

Authors:  Heidi Palosaari; Caroline J Pennington; Markku Larmas; Dylan R Edwards; Leo Tjäderhane; Tuula Salo
Journal:  Eur J Oral Sci       Date:  2003-04       Impact factor: 2.612

10.  Amelogenin post-translational modifications: carboxy-terminal processing and the phosphorylation of bovine and porcine "TRAP" and "LRAP" amelogenins.

Authors:  A G Fincham; J Moradian-Oldak
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

View more
  6 in total

1.  Biomimetic Precipitation of Uniaxially Grown Calcium Phosphate Crystals from Full-Length Human Amelogenin Sols.

Authors:  Vuk Uskoković; Wu Li; Stefan Habelitz
Journal:  J Bionic Eng       Date:  2011-06-10       Impact factor: 2.682

2.  Biophysical characterization of synthetic amelogenin C-terminal peptides.

Authors:  Feroz Khan; Wu Li; Stefan Habelitz
Journal:  Eur J Oral Sci       Date:  2012-02-11       Impact factor: 2.612

3.  Zeta-potential and particle size analysis of human amelogenins.

Authors:  V Uskokovic; Z Castiglione; P Cubas; L Zhu; W Li; S Habelitz
Journal:  J Dent Res       Date:  2009-12-29       Impact factor: 6.116

4.  The proteolytic processing of amelogenin by enamel matrix metalloproteinase (MMP-20) is controlled by mineral ions.

Authors:  Feroz Khan; Haichuan Liu; Aileen Reyes; H Ewa Witkowska; Olga Martinez-Avila; Li Zhu; Wu Li; Stefan Habelitz
Journal:  Biochim Biophys Acta       Date:  2013-03

5.  Dynamic light scattering and zeta potential of colloidal mixtures of amelogenin and hydroxyapatite in calcium and phosphate rich ionic milieus.

Authors:  Vuk Uskoković; Roselyn Odsinada; Sonia Djordjevic; Stefan Habelitz
Journal:  Arch Oral Biol       Date:  2010-12-10       Impact factor: 2.633

6.  Hydrolysis of amelogenin by matrix metalloprotease-20 accelerates mineralization in vitro.

Authors:  Vuk Uskoković; Feroz Khan; Haichuan Liu; Halina Ewa Witkowska; Li Zhu; Wu Li; Stefan Habelitz
Journal:  Arch Oral Biol       Date:  2011-07-20       Impact factor: 2.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.